Comparing the Quality of Life (QoL) of patients with Maintenance Treatment (MT) versus No Maintenance Treatment (MT) in Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT).
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Dec 2017 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.